Mizuho gave a cautious coverage initiation on Aflac Inc (
AFL), citing its stagnant sales growth. Various asset management firms have adjusted their holdings in Aflac, affecting its share distribution. Aflac ventured into a digital distribution tie-up with
Ethos, expanding its reach in supplemental health. Additionally, an increase has been announced in shares authorized for repurchase. AFL's recent valuation was reassessed after its 4% pullback.
Morgan Stanley maintained its
Equal Weight rating on AFL, while
Mizuho upgraded AFL to
Strong Sell. Insider selling was observed as AFL's EVP sold 5,492 shares of stock. AFL's stock showed weakness but its financial prospects look decent. Q3 Earnings beat estimates propelling a surge in stock. A new initiative, 'Beyond Words' book release was observed to foster stakeholder loyalty with proceeds going to cancer care. Notably, Aflac reported net earnings of $1.6 billion in its Third Quarter results. Aflac's Q2 earnings stood out among the rest of the life insurance stocks. A notable milestone was Aflac's dividend announcement of $0.58. Aflac's previous investment performance was acknowledged as a $1000 investment a decade ago would have multiplied multiple times today. In recent activities, analysts estimate a decline in earnings, however, AFL's price target has been raised to $120 from $118 by Morgan Stanley.
Aflac AFL News Analytics from Thu, 03 Apr 2025 07:00:00 GMT to Sat, 20 Dec 2025 08:46:56 GMT -
Rating -2
- Innovation -1
- Information 8
- Rumor 0
